Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

86.90 +0.88 (+1.03%)
Streaming Delayed Price Updated: 2:14 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
2 Dependable Dividend Stocks That Can Pay You for Life
Via The Motley Fool
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Analyst Expectations For Medtronic's Future
Via Benzinga
MEDTRONIC PLC (NYSE:MDT) is setting up nicely for a breakout.
MEDTRONIC PLC (NYSE:MDT) Reveals Intriguing Technical Aspects. Indications Suggest NYSE:MDT Could Be on the Verge of a Breakout. Here's What You Need to Know. 
Via Chartmill
Medtronic Stock Gets IBD Rating Lift
In a welcome move, Medtronic stock saw its Relative Strength Rating improve to 73 on Tuesday, up form 67 a day earlier. 
Via Investor's Business Daily
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency. 
Via Benzinga
Is Medtronic Stock a Buy?
The medical device maker has been a huge winner for its long-term shareholders. 
Via The Motley Fool
Why Medtronic Stock Is Sinking Today
Via The Motley Fool
Why Medtronic Just Undercut Its Buy Zone With A 5% Drop
The company reported fiscal third-quarter earnings and, on at least one metric, disappointed investors. 
Via Investor's Business Daily
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
Via The Motley Fool
MarketBeat Week in Review – 02/17 - 02/21
Stocks were volatile this week as bad news gave investors a reason to sell; that volatility will continue next week with key retail earnings and inflation news 
Via MarketBeat
Topics Economy
Medtronic’s Expansion Gains Momentum—Time for a Market Shift?
Medtronic is on track to complete a market reversal later this year as investments in technology and innovation begin to pay off. 
Via MarketBeat
The Smartest Dividend Stocks to Buy With $1,000 Right Now
Via The Motley Fool
Medtronic Unusual Options Activity For February 14
Via Benzinga
The Analyst Verdict: Medtronic In The Eyes Of 5 Experts
Via Benzinga
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Hunting
The company said its medical-surgical segment struggled with ongoing stapling market pressures and temporary shifts in U.S. distributor buying patterns. 
Via Stocktwits
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Stay informed with the top movers within the S&P500 index on Tuesday.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session. 
Via Chartmill
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday. 
Via Benzinga
Medtronic (MDT) Q3 2025 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Which S&P500 stocks are gapping on Tuesday?
Let's take a look at the S&P500 stocks that are experiencing notable price gaps in today's session on Tuesday. Discover the gap up and gap down stocks in the S&P500 index. 
Via Chartmill
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
Medtronic reported Q3 revenue of $8.29 billion, missing estimates, while EPS of $1.39 topped forecasts. The company reaffirmed its FY25 organic growth guidance. 
Via Benzinga
US Stocks Likely To Open Higher Amid Ukraine Peace Talk Hopes As Russian, American Officials Meet
U.S. stock futures rose on Tuesday following a mixed close on Friday after the Presidents' Day holiday on Monday. 
Via Benzinga
Earnings Scheduled For February 18, 2025
Via Benzinga
Dow Dips Over 150 Points, But Records Weekly Gain: Investor Sentiment Improves, Greed Index In 'Fear' Zone
Via Benzinga
Topics Stocks
Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom
DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential. 
Via Benzinga
9 Dividend Kings In The Next 5 Years
Here are 9 stocks have at least 45 years of dividend increases, meaning it’s just a matter of time until they reach the Dividend Kings list. 
Via Talk Markets
Topics Stocks / Equities
3 High-Yield Dividend Stocks I Can't Wait to Buy to Boost My Passive Income
Via The Motley Fool
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.